Not Signed In - AlphaVax Announces Clinical Trials For Influenza And CMV
Tue, 30 Jan 2007 08:00 AM EST
... AlphaVax has been given approval by the Food and Drug Administration (FDA) to begin clinical trials evaluating vaccines for influenza and cytomegalovirus (CMV) developed with the company's alphavaccine technology. "These trials will expand on our previous clinical experience with an HIV vaccine to two additional indications, influenza and CMV," said Jeff Chulay, M.D. [click link for full article] ...
Related Topics
- Clinical Trials
- Cmv
- Influenza
- Pharmacology
- Psychopharmacology
- Influenza and Colds
- Cytomegalovirus / Cmv
- Clinical Growth Charts
- CMV esophagitis
- CMV - pneumonia
- CMV - immunocompromised host
- CMV - gastroenteritis/colitis
- Acute cytomegalovirus (CMV) infection
- Pediatric Aids
- Influenza Virus Vaccine
- Influenza Vaccines
- Influenza (Flu)
- Influenza (flu) Vaccine
- H1N1 (swine) influenza
- Influenza Surveillance Data
email this page
print this page
bookmark this page
feedback on this page
